long-term

S.Pellegrino Announces Long-term Partnership with Ferrari to Inspire Consumers to Bring Their Best

The strategic alliance aims to elevate S.Pellegrino's premium lifestyle positioning, expand engagement with younger audiences and enhance its global brand…

2 days ago

Virtualware to strengthen its Board with two new independent directors, reinforcing the companys governance and long-term strategy

Bilbao, 1 December — Virtualware (EPA: ALVIR), a pioneer in 3D-driven enterprise software, will strengthen its Board of Directors with…

5 days ago

Sunsure Energy signs long-term renewable power agreement with Bisleri International for its Sahibabad facility

The partnership will enable Bisleri to meet 48% of its electricity needs through renewable energy, while offsetting close to 2,700…

1 week ago

PhoneX Holdings, Inc. Announces Board Change and Adoption of Long-Term Incentive Plan

New York, NY, Nov. 25, 2025 (GLOBE NEWSWIRE) -- PhoneX Holdings, Inc. (“PhoneX” or the “Company”) (OTC Pink: PXHI) today…

1 week ago

CoinW’s Eight-Year Marathon: Driving Long-Term Ecosystem Growth

HONG KONG, Nov. 17, 2025 /PRNewswire/ -- CoinW, a leading global crypto asset trading platform, has officially concluded its 8th-anniversary…

3 weeks ago

George Medicines presents long-term efficacy and safety data for single pill triple combination therapy for hypertension at American Heart Associations Scientific Sessions 2025

London, UK, Boston, MA, 9 November 2025 – George Medicines, a late-stage biopharmaceutical company focused on addressing significant unmet needs…

4 weeks ago

SpringWorks Therapeutics Announces Publication of Long-Term Efficacy and Safety Data from the Phase 3 DeFi Trial of OGSIVEO (nirogacestat) in Adults with Desmoid Tumors in the Journal of Clinical Oncology

Long-term continuous OGSIVEO treatment for up to 4 years was associated with further tumor size reductions, increase in objective response…

2 months ago

Tensive publishes positive long-term clinical follow-up data in Breast Cancer on REGENERA / SOFTAG breast implant

24-month Phase I follow-up data show positive outcomes are maintained High levels of investigator and patient satisfaction, excellent safety profileOngoing registrational…

2 months ago

New Long-term Safety Data from the Completed Phase 3 SOLARIS Trial Support the Potential of Olanzapine LAI (TEV-‘749) as the First Long-Acting Olanzapine Treatment Option for Schizophrenia with No PDSS Observed

Through Week 56 in the SOLARIS trial, there were no suspected or confirmed post-injection delirium/sedation syndrome (PDSS) events observed with…

3 months ago

Monopar to Present New Long-Term Neurological Efficacy and Safety Data for ALXN1840 in Wilson Disease at the 150th American Neurological Association Annual Meeting

WILMETTE, Ill., Sept. 14, 2025 (GLOBE NEWSWIRE) -- Monopar Therapeutics Inc. (“Monopar” or the “Company”) (Nasdaq: MNPR), a clinical-stage biopharmaceutical…

3 months ago